Wed, May 26, 2021
Tue, May 25, 2021
Mon, May 24, 2021
Fri, May 21, 2021
Thu, May 20, 2021
Wed, May 19, 2021
Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021

Asthika Goonewardene Upgraded (ALLO) to Strong Buy and Increased Target to $41 on, May 20th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-41-on-may-20th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Asthika Goonewardene of Truist Securities, Upgraded "Allogene Therapeutics, Inc." (ALLO) to Strong Buy and Increased Target from $34 to $41 on, May 20th, 2021.

Asthika has made no other calls on ALLO in the last 4 months.



There are 3 other peers that have a rating on ALLO. Out of the 3 peers that are also analyzing ALLO, 0 agree with Asthika's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Asthika


  • Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $52 on, Friday, May 14th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $43 on, Monday, March 1st, 2021
  • Benjamin Burnett of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $43 on, Tuesday, January 26th, 2021

Publication Contributing Sources